Sees FY25 adjusted EBITDA $144M-$154M. The company continues to experience strong customer retention and late-stage pipeline activity.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVH:
- Evolent Health reports Q3 adjusted EPS 5c, consensus 10c
- Evolent Health’s Strategic Exit and Profitability Boost Underpin Buy Rating
- Micron reports Q4 beat, Instagram reports 3B MAUs: Morning Buzz
- Closing Bell Movers: Micron up marginally after initial post-earnings spike
- Evolent Health Divests Primary Care Business to Privia